Publications by authors named "Janis Fleming"

Claim this Profile
C
Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Rachana Patel, Catriona A Ford, Lisa Rodgers, Linda K Rushworth, Janis Fleming

Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
Carolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, Noor A Nam, John Knight, Janis Fleming

Oncogene· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
Carolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, Noor A Nam, John Knight, Janis Fleming

Oncogene· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.
Rachana Patel, Janis Fleming, Ernest Mui, Carolyn Loveridge, Peter Repiscak

EMBO Mol Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.
Prabhakar Rajan, Jacqueline Stockley, Ian M Sudbery, Janis T Fleming, Ann Hedley

BMC Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
Prabhakar Rajan, Ian M Sudbery, M Eugenia M Villasevil, Ernest Mui, Janis Fleming

Eur Urol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?
Haley L Bennett, Jacqueline Stockley, Janis T Fleming, Ranadip Mandal, Jim O'Prey

BJU Int· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
Rachana Patel, Meiling Gao, Imran Ahmad, Janis Fleming, Lukram B Singh

J Clin Invest· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis.
Meiling Gao, Rachana Patel, Imran Ahmad, Janis Fleming, Joanne Edwards

EMBO Mol Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.
Carolyn Wiltshire, Babloo L Singh, Jacqueline Stockley, Janis Fleming, Brendan Doyle

Mol Cancer Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells.
James A McCaul, Katrina E Gordon, Fay Minty, Janis Fleming, E Kenneth Parkinson

Oral Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent routes to oral cancer.
Keith D Hunter, Johanna K Thurlow, Janis Fleming, Paul J H Drake, J Keith Vass

Cancer Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells.
Jim O'Prey, Judith Brown, Janis Fleming, Paul R Harrison

Biochem Pharmacol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-beta: but p53 mutations are not necessarily required.
Alessandra Muntoni, Janis Fleming, Katrina E Gordon, Keith Hunter, Fiona McGregor

Oncogene· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
Fiona McGregor, Alessandra Muntoni, Janis Fleming, Judith Brown, David H Felix

Cancer Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis